Image

Global Cancer Nanomedicine Market – Industry Trends and Forecast to 2030

Healthcare

Image

Global Cancer Nanomedicine Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Cancer Nanomedicine Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 180.00 Billion
Diagram Market Size (Forecast Year) USD 445.67 Billion
Diagram CAGR %

Major Markets Players

  • Alnylam Pharmaceuticals
  • Amgen
  • Arrowhead Pharmaceuticals
  • AstraZeneca
  • Cadila Pharmaceuticals

Global Cancer Nanomedicine Market, By Type (Inorganic Nanoparticles, Organic Nanoparticles), Agent Type (Diagnostic Agents, Therapeutic Agents, Drug Delivery Agents), Mechanism (Targeting Tumor Cells, Nanocarrier - Drug Complex, Drug Release Systems), Cancer Type (Breast Cancer, Pancreatic Cancer, Brain Cancer, Lung Cancer, Others), Imaging Technique (Positron Emission Tomography, Single Photon Emitted Tomography, Magnetic Resonance Imaging (MRI)), Phase (Research, Preclinical, Phase-I, Phase-I/II, Phase-II, Phase-III) – Industry Trends and Forecast to 2030.

Cancer Nanomedicine Market

 Cancer Nanomedicine Market Analysis and Size

According to the International Agency for Research on Cancer, there will be 10.3 million cancer deaths and 19.3 million new cancer cases worldwide in 2020. Furthermore, 16.4 million people are expected to die from cancer-related causes by 2040, with 29.5 million new patients diagnosed each year. One of the primary reasons for the increasing prominence of nanomedicine is the rise in the prevalence of chronic diseases such as cancer and cardiovascular disease. Furthermore, the market for cancer nanomedicine is expanding due to increased number of patients with high blood pressure, obesity, and other cardiovascular diseases, among other factors.

Data Bridge Market Research analyses that the cancer nanomedicine market which was USD 180 billion in 2022, is expected to reach USD 445.67 billion by 2030, at a CAGR of 12% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cancer Nanomedicine Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Inorganic Nanoparticles, Organic Nanoparticles), Agent Type (Diagnostic Agents, Therapeutic Agents, Drug Delivery Agents), Mechanism (Targeting Tumor Cells, Nanocarrier - Drug Complex, Drug Release Systems), Cancer Type (Breast Cancer, Pancreatic Cancer, Brain Cancer, Lung Cancer, Others), Imaging Technique (Positron Emission Tomography, Single Photon Emitted Tomography, Magnetic Resonance Imaging (MRI)), Phase (Research, Preclinical, Phase-I, Phase-I/II, Phase-II, Phase-III)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Alnylam Pharmaceuticals, Inc. (U.S.), Amgen Inc. (U.S.), Arrowhead Pharmaceuticals, Inc. (U.S.), AstraZeneca (U.K.), Cadila Pharmaceuticals (India), CELGENE CORPORATION (U.S.), Celsion Corporation (U.S.), Genzyme (U.S.), Merck & Co., Inc. (U.S.), Nippon Kayaku Co.,Ltd. (Japan), Nanobiotix (France), Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Takeda Pharmaceutical Company Limited (Japan), General Electric (U.S.), Johnson & Johnson Services, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Gilead Sciences, Inc. (U.S.), Novartis AG (Switzerland)

Market Opportunities

  • Increasing Demand for Nanomedicines

Market Definition

Nanomedicine is a branch of nanotechnology that uses nanoparticles to diagnose, treat, monitor, and control biological systems. By manipulating materials at the nanoscale, it improves medicine delivery. As a result, nanomedicine has helped treat a wide range of diseases. Nanomedicine is still in its infancy, with numerous products in the works. Nanobiotix has identified 230 nanomedicine products that are either patented or in the early stages of development. 49 of the 230 products are on the market, while the remaining 122 are in clinical trials, either in Phase II or Phase III trials.

Global Cancer Nanomedicine Market Dynamics

Drivers

  • New product launches

Nanotechnology-based liposome products may be considered one of the most advanced segments of oncology medications. For instance, Ortho Pharmaceuticals' Doxil was one of the first cancer nanomedicines approved by the US FDA in 1995 for treating AIDS-related Kaposi's sarcoma. DaunoXome by Galen Ltd is a liposomal formulation used to treat HIV-related Kaposi sarcoma, and clinical trials for this medicine in leukaemia are also being conducted. More products are in various stages of clinical trials and will be introduced into the global market in the coming years.

  • Usage of nanoparticle-based imaging agents

Because of their small size, nanoparticles are easily absorbed by cells and researchers used this property to aid in disease diagnosis. Oncologists can gain a better understanding of tumour shape and size, as well as precise location, for better treatment. A few nanoparticle-based imaging agents on the market are used for Magnetic Resonance (MR) imaging. SPIO nanoparticles used in imaging include Endorem by Guerbet, Resovist by Bayer, and Feridex by Berlex Laboratories. Aside from oncology, they are also used to diagnose cardiovascular and neurological diseases, propelling the market's growth.

Opportunities

  • Increasing Demand for Nanomedicines

The growing demand for nanomedicines can be attributed to the rapidly expanding applications of nanomaterials such as nanocapsules and nanotubes in drug delivery systems. The rise in cancer and cardiovascular disease incidences has boosted demand for nanomedicines, resulting in increased public and private investment in nanomedicine research and advancements in biodegradable nanoparticles. The cost-effectiveness and fewer side effects of these therapies are also major drivers of the cancer nanomedicine industry's growth.

Restraints/Challenges

  • Side effects associated with the consumption of nanoparticles

The low rate of adoption, the increasing side effects associated with the consumption of nanoparticles, and the stringent regulatory framework for drug approvals are acting as market restraints for the growth of the cancer nanomedicine market during the forecast period.

This cancer nanomedicine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cancer nanomedicine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Cancer Nanomedicine Market

According to reports, COVID-19 positively impacts the cancer nanomedicine market. This was due to increased demand for nanomedicines to treat medical conditions similar to cancer. Furthermore, nanomedicine applications opened up new avenues for the development of innovative solutions for the prevention, detection, and treatment of viral diseases such as the COVID-19 virus, boosting the growth of the cancer nanomedicine industry. The active involvement of well-established pharmaceutical companies in the development of novel Nano science-based therapeutics is expected to influence market growth. Furthermore, advances in nanotechnology and its expanding applications in preventive interventions, early disease diagnosis, chronic and acute disorder prevention, and acute and chronic disorder prophylaxis of acute as well as chronic disorders are the factors expected to drive the cancer nanomedicine industry growth.

Recent developments

  • In 2021, The national nanotechnology effort received more than USD 1.7 billion in funding from the US government, highlighting the importance of nanotechnology. Furthermore, Forbes ranks nanotechnology as the sixth most important growth technology to watch over the next ten years.

Global Cancer Nanomedicine Market Scope

The cancer nanomedicine market is segmented on the basis of type, agent type, mechanism, cancer type, imaging technique, and phase. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Inorganic Nanoparticles
  • Synthesis of gold nanoparticle
  • Organic Nanoparticles
  • Polymeric nanoparticle
  • lipid organic nanoparticles

 Agent Type

  • Diagnostic Agents
  • Cancer biomarkers
  • Diagnostic device
  • Biosensors
  • Microarrays
  • Nanoprobes
  • Quantum dots
  • Therapeutic Agents
  • Photodynamic therapy
  • Photo thermal therapy
  • Drug Delivery Agents

 Mechanism

  • Targeting Tumor Cells
  • Passive targeting
  • Active targeting
  • Nanocarrier - Drug Complex
  • Liposomes
  • Dendrimers
  • Micelles
  • Inorganic nanocarriers
  • Drug Release Systems

Cancer Type

  • Breast Cancer
  • Pancreatic Cancer
  • Brain Cancer
  • Lung Cancer
  • Others

 Imaging Technique

  • Positron Emission Tomography
  • Single Photon Emitted Tomography
  • Magnetic Resonance Imaging (MRI)

 Phase

  • Research
  • Preclinical
  • Phase-I
  • Phase-I/II
  • Phase-II
  • Phase-III

Cancer Nanomedicine Market Regional Analysis/Insights

The cancer nanomedicine market is analyzed and market size insights and trends are provided by country, type, agent type, mechanism, cancer type, imaging technique, and phase as referenced above.

The countries covered in the cancer nanomedicine market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cancer nanomedicine market due to the growing number of research and development activities along with the prevalence of various start-ups organizations.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the surging levels of investment for research and development activities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Cancer Nanomedicine Market Share Analysis

The cancer nanomedicine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cancer nanomedicine market.

Some of the major players operating in the cancer nanomedicine market are:

  • Alnylam Pharmaceuticals, Inc. (U.S.)
  • Amgen Inc. (U.S.)
  • Arrowhead Pharmaceuticals, Inc. (U.S.)
  • AstraZeneca (U.K.)
  • Cadila Pharmaceuticals (India)
  • CELGENE CORPORATION (U.S.)
  • Celsion Corporation (U.S.)
  • Genzyme (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Nippon Kayaku Co.Ltd. (Japan)
  • Nanobiotix (France)
  • Pfizer Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Takeda Pharmaceutical Company Limited (Japan)
  • General Electric (U.S.)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Gilead Sciences, Inc. (U.S.)
  • Novartis AG (Switzerland)

Research Methodology: Global Cancer Nanomedicine Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report. 


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The cancer nanomedicine market size will be worth USD 445.67 billion by 2030.
The growth rate of the cancer nanomedicine market is 12% in the forecast period by 2030.
New product launches & Usage of nanoparticle-based imaging agents are the growth drivers of the cancer nanomedicine market.
Type, agent type, mechanism, cancer type, imaging technique, and phase are the factors on which the cancer nanomedicine market research is based.
Major companies in the cancer nanomedicine market are Alnylam Pharmaceuticals, Inc. (U.S.), Amgen Inc. (U.S.), Arrowhead Pharmaceuticals, Inc. (U.S.), AstraZeneca (U.K.), Cadila Pharmaceuticals (India), CELGENE CORPORATION (U.S.), Celsion Corporation (U.S.), Genzyme (U.S.), Merck & Co., Inc. (U.S.), Nippon Kayaku Co.,Ltd. (Japan), Nanobiotix (France), Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Takeda Pharmaceutical Company Limited (Japan), General Electric (U.S.), Johnson & Johnson Services, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Gilead Sciences, Inc. (U.S.), Novartis AG (Switzerland).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials